Filter
688
Filtered Results: 688
Text search:
biosafety
Featured
Recommendations
105
New Publications
164
Language
Document type
No document type
336
Guidelines
161
Studies & Reports
74
Manuals
54
Strategic & Response Plan
34
Training Material
9
Fact sheets
8
Situation Updates
5
Resource Platforms
5
Brochures
1
Infographics
1
Countries / Regions
India
46
Sierra Leone
28
Latin America and the Carribbean
24
Nigeria
22
Africa
19
Western and Central Europe
18
Liberia
17
Kenya
15
Global
15
Rwanda
13
Uganda
13
Brazil
13
Ghana
12
Eastern Europe
11
Mozambique
10
West and Central Africa
10
Ethiopia
10
Nepal
9
Ukraine
9
Guinea
9
Syria
8
Congo, Democratic Republic of
8
Middle East and North Africa
8
East and Southern Africa
8
Angola
8
Tanzania
7
Bangladesh
7
Zambia
7
Philippines
6
South–East Asia Region
6
Russia
6
Burkina Faso
5
Malawi
5
South Africa
5
Pakistan
5
Guinea-Bissau
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Spain
4
Yemen
4
Myanmar / Burma
4
Tajikistan
3
Chile
3
Senegal
3
Afghanistan
3
Namibia
3
South Sudan
3
Colombia
2
Cameroon
2
Peru
2
USA
2
Cambodia
2
Germany
2
Saudi Arabia
2
Bolivia
2
Lebanon
2
Moldova
2
Sudan
2
Georgia
2
Central African Republic
2
North Macedonia
1
Mexico
1
Togo
1
China
1
Iran
1
Albania
1
Laos
1
Burundi
1
Zimbabwe
1
Morocco
1
Bulgaria
1
Mauritania
1
Italy
1
Armenia
1
Asia
1
Venezuela
1
Hungary
1
Jordan
1
Paraguay
1
North America
1
Gabon
1
Mauritius
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Vietnam
1
Sri Lanka
1
Romania
1
Slovakia
1
Greece
1
Palestine
1
Poland
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Indonesia
1
Iraq
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
251
Clinical Guidelines
55
Pharmacy & Technologies
54
Key Resources
28
Public Health
27
Women & Child Health
7
Capacity Building
1
Toolboxes
COVID-19
156
TB
113
Rapid Response
86
Ebola
71
AMR
39
HIV
20
NTDs
18
Planetary Health
16
Conflict
13
Zika
11
Pharmacy
10
Caregiver
9
Polio
9
Specific Hazards
7
Natural Hazards
5
Cholera
3
Mental Health
2
Health Financing Toolbox
2
Refugee
1
Global Health Education
1
Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas
recommended
Short Version
This clinical practice guideline was developed in order to provide recommendations for the management of critically ill adult patients with COVID-19 in intensive care units (ICUs).
v.1 (3 de abril de 2020)
Este guia de prática clínica fornece recomendações baseadas em evidências para o controle de infecção, coleta de amostras, cuidados de suporte, tratamento medicamentoso e prevenção de complicações. As recomendações são dirigidas a todos os profissionais de sa...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of ...
Центр лечения тяжелых острых респираторных инфекцийПрактическое руководство по организации центра лечения ТОРИ ицентра проведения скрининга на ТОРИ на базе мед...
آذار / مارس 2020مركز معالجة حالات العدوى التنفسیة الحادة الوخیمةدلیل عملي لإنشاء وإدارة مركز لمعالجة حالات العدوى التنفسیة الحادة الوخیمة وقسم لتحري المصابین بھذه ا...
It is targeted towards humanitarian settings and aims to complement other guidance on the management of the dead with a stronger focus on the practical realities faced when dealing with the dead in humanitarian settings. The guidance offers practical recommendations for the management of the bodies ...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
Interim practical manual supporting implementation of the WHO guidelines on core components of infection prevention and control programmes
The number of confirmed COVID-19 cases detected and reported in each country is influenced by
many factors including limited access and/or utilization of healthcare and COVID-19 testing, limited
surveillance, lack of knowledge amongst the population about when to seek testing, an asymptomatic pres...
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
The COVID-19 pandemic is a multiplier of vulnerability, compounding threats to food insecurity, while exposing weaknesses in food and health systems. It is severely undermining the capacity of communities to cope in times of crisis and has become a stress test for political and economic stability.
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
